Insider Cluster (3 insiders) ·Filed Apr 30, 2026
Insider cluster: 3 insiders, $0.4M total
Actionable Insight • Neutral
Insider selling is routine and not actionable. Monitor upcoming earnings for any fundamental changes, but no immediate trading signal from this cluster.
Final — all horizons settled through T+60d ⚠ clustered
EBS ▼ -10.94% at T+60d
NEUTRAL call ✗ call lost -10.94% · α vs SPY -14.04% · entry $8.23 → $7.33
T+1d
+2.92%
call +2.92% · α +2.70%
$8.47
settled 5mo ago
T+5d
+10.57%
call +10.57% · α +8.84%
$9.10
settled 5mo ago
T+20d
+11.54%
call +11.54% · α +6.58%
$9.18
settled 4mo ago
T+60d
-10.94%
call -10.94% · α -14.04%
$7.33
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Three directors of Emergent BioSolutions sold a total of approximately $385K in open-market shares over two days, representing less than 0.1% of market cap. This is routine insider selling, not indicative of material concerns, especially given concurrent non-cash stock grants to the same directors.
Key Financial Metrics
Direction
selling
Total Value
$385.0K
Insiders
3
Key Facts
- 3 directors sold shares: Katkin Keith ($128K), DeGolyer Donald W ($121K), Zoon Kathryn C ($135K)
- Total open-market sales: ~$385K, ~0.09% of $437M market cap
- All sales occurred at ~$8.28-$8.36 per share on April 30 and May 1, 2026
- Multiple directors also received non-cash stock grants (A) on April 30, 2026
Financial Impact
Total insider sales of $385K are trivial relative to $437M market cap
insider ownership
Risk Factors
- Further insider selling if negative news emerges
- No C-suite participation reduces signal
Market Snapshot
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (6 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EBS-1777930260656 |
16 reports for EBS
60% Hit rate best @ T+20▲ +14.89%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | Press Release | $4.45 $5.68 | ▼ −27.64% | ▼ −28.70% | $6.29 (−41.35%) |
Jun 29, 2026 13w ago | 8-K | $8.46 $7.26 | ▼ −14.18% | ▼ −13.90% | $6.29 (−25.65%) |
Jun 4, 2026 17w ago | Press Release | $8.44 $8.28 | ▼ −1.90% | ▼ −0.52% | $6.29 (−25.47%) |
Apr 30, 2026 22w ago | Press Release | $8.47 $8.49 | ▲ +0.24% | ▼ −5.05% | $6.29 (−25.74%) |
Apr 30, 2026 22w ago | Insider Cluster | $8.23 $9.18 | ▲ +11.54% | ▲ +6.58% | $6.29 (−23.57%) |
Apr 29, 2026 22w ago | Press Release | $7.99 $9.18 | ▲ +14.89% | ▲ +8.85% | $6.29 (−21.28%) |
Apr 29, 2026 22w ago | Press Release | $7.99 $9.18 | ▲ +14.89% | ▲ +8.85% | $6.29 (−21.28%) |
Apr 28, 2026 22w ago | DEFA14A | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Apr 28, 2026 22w ago | Press Release | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Apr 27, 2026 22w ago | DEFA14A | $8.23 $9.13 | ▲ +10.94% | ▲ +5.47% | $6.29 (−23.57%) |
Showing 10 of 16
US Market Status
Market Open — Closes in 2h 13m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access